PXL/HO/Cir-066/2018-19                                                                                        Dt: 22.11.2018

Hyderabad

Dear Sir/Madam

Subject: Workshop on “Regulatory practices in China and Dossier filing with NMPA (formerly CFDA)” on 17^thDec.2018 at Hyderabad.

Members are kindly aware, recently the regulatory requirements of China for product registration undergone many changes and guidelines of the National Medical Products Administration, China(formerly CFDA), which will likely have an impact on the dossier filing and timelines of the product approvals.

Pharmexcil with a view to create awareness on the recent developments is organising a full day workshop in association with M/s. China Chinopharma Ltd, one of the major trading company , on the product registration guidelines and dossier filing with The National Medical Products Administration(NMPA –formerly CFDA) for the benefit of our member companies.

The details of the programme are as follow:

Date : 17th December 2018
Timings: 9 am to 5pm
Venue: Hyderabad (Hotel details will be finalized and shared with next circular)

The workshop will have sessions on the NMPA recent regulatory requirements and technical guidelines for Dossier filling with NMPA and guidance on facing audits, challenges and opportunities under the update guidelines.

Member companies interested to participate in the workshop are requested to register their participation by sending email to dgdesk@pharmexcil.com. Kindly note that the seats are limited.

With regards,